# Biosimilar vs Maudsley Deprescribing Guide

The clearest difference is price: Maudsley Deprescribing Guide at Free against Biosimilar's $1.99. Maudsley Deprescribing Guide also leads on iOS requirement (13.0 vs 17.6). Biosimilar's advantage is rating (5.0 vs 1.0) and in-app purchases (none vs 1). On ratings volume and device support there is nothing between them.

Maudsley Deprescribing Guide is free to download; Biosimilar costs $1.99 up front. Maudsley Deprescribing Guide sells 1 one-off in-app purchase. Biosimilar asks for nothing beyond the download.

Biosimilar holds the better App Store score, 5.0 against 1.0. Both are backed by a comparable volume of ratings — 2 and 1 respectively.

## The numbers

| Metric | Biosimilar | Maudsley Deprescribing Guide |
| --- | --- | --- |
| Price | $1.99 | **Free** |
| Rating | **[5.0 (2 ratings)](https://appshunter.io/ios/app/biosimilar/id1661974746/reviews)** | [1.0 (1 ratings)](https://appshunter.io/ios/app/maudsley-deprescribing-guide/id6747700115/reviews) |
| Number of ratings | **2** | 1 |
| Positive reviews | — | 0.0% of reviews |
| In-app purchases | **No** | Yes |
| Ads | **No** | Yes |
| Update frequency | Every 3 months | — |
| Monetization | Paid | **Free with in-app purchases** |
| Size | 2 MB | 149 MB |
| Requires iOS | 17.6 | **13.0** |
| Devices | iPhone, iPad | **iPhone, iPad, iPod** |
| Age rating | 17+ | 17+ |
| Developer | [Dabbling Badger LLC](https://appshunter.io/developer/455874932) | [Skyscape Medpresso Inc](https://appshunter.io/developer/818609416) |

## What reviewers say

### Biosimilar

[App page](https://appshunter.io/ios/app/biosimilar/id1661974746)

This app serves as a reference for biosimilar and interchangeable biologic drugs, drawing from the FDA's Purple Book. It offers essential prescribing and dispensing information for healthcare professionals managing complex drug therapeutics.

**Highlights:** FDA Purple Book reference, Prescribing information, Dispensing guidance, Biologic drug data, Interchangeable product details

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


### Maudsley Deprescribing Guide

[App page](https://appshunter.io/ios/app/maudsley-deprescribing-guide/id6747700115)

This app offers evidence-based guidance for healthcare professionals and interested individuals on safely discontinuing psychiatric medications. It covers antidepressants, benzodiazepines, gabapentinoids, and Z-drugs, providing principles, tapering regimens, and troubleshooting for withdrawal symptoms. The free version includes sample content, with full access available via in-app purchase.

**Highlights:** Evidence-based deprescribing guidelines, Covers antidepressants, benzodiazepines, gabapentinoids, Z-drugs, Patient-centered approach, Distinguishes withdrawal from underlying symptoms, Hyperbolic tapering guidance, Step-by-step tapering regimens, Troubleshooting withdrawal issues

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases (1)**

| Purchase | Price | Billing |
| --- | --- | --- |
| Maudsley Deprescribing Guide | $48.99 | one-time |


## Frequently asked questions

### Is Biosimilar free?

Biosimilar costs $1.99, with no in-app purchases.

### Is Maudsley Deprescribing Guide free?

Maudsley Deprescribing Guide is free to download, with in-app purchases available.

### Which has better reviews, Biosimilar or Maudsley Deprescribing Guide?

Biosimilar is rated higher. Biosimilar averages 5.0 out of 5 from 2 ratings, while Maudsley Deprescribing Guide averages 1.0 from 1 ratings.

### Do Biosimilar or Maudsley Deprescribing Guide have ads?

Maudsley Deprescribing Guide shows ads; Biosimilar does not.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*